Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 91 (7) , 423-426
- https://doi.org/10.1016/s0954-6111(97)90257-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Survival Analysis of Untreated Patients With Non-Small-Cell Lung CancerChest, 1994
- Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.Journal of Clinical Oncology, 1993
- Combined-modality therapies for non-small cell lung cancerAnnals of Oncology, 1992
- Reporting results of cancer treatmentCancer, 1981